Abstract
Non-thyroid neoplasia were analysed by Southern blot of genomic DNA and DNA prepared by reverse transcription and amplification by polymerase chain reaction (RT/PCR) for the activation of the RET oncogene. It is known that the rearrangement of RET occurs in about 10%-20% of human thyroid papillary carcinomas. None of 528 non-thyroid tumours showed rearrangement of the RET proto-oncogene, whereas three out of 30 thyroid papillary carcinomas were positive for RET activation. Therefore the activation of RET seems to be a somatic cell mutation specific to human thyroid carcinomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santoro, M., Sabino, N., Ishizaka, Y. et al. Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer 68, 460–464 (1993). https://doi.org/10.1038/bjc.1993.370
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.370
This article is cited by
-
Molecular genetics and diagnosis of thyroid cancer
Nature Reviews Endocrinology (2011)
-
RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH
British Journal of Cancer (2006)
-
Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas
Oncogene (2001)
-
TheRET proto-oncogene: A challenge to our understanding of disease pathogenesis
Pediatric Surgery International (1997)